Pressure Biosciences, Inc. (PBIO) Income Statement

Click line-items for a historical chart and %

PCT Products, services, other
Grant revenue	34.39K
Total revenue
Cost of PCT products and services
Research and development	268.32K
Selling and marketing	224.38K
General and administrative	231.55K
Total operating costs and expenses	987.14K
Operating loss	-451.81K
Interest income
Warrant income relating to revaluation	623.13K
Net loss	-945.21K
Accrued and deemed dividends on convertible preferred stock	0
Net loss applicable to common shareholders	-945.21K
Net loss per share attributable to common stockholders - basic and diluted (in dollars per share)	-0.03
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation (in shares)

Entities mentioned with PBIO

View All Entities